Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "neurology"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"Canadian Agency for Drugs and Technologies in Health"
product_txtF_mv:"National Center for Biotechnology Information"
Showing
1
-
20
of
37
Search:
'"neurology"'
,
query time: 0.06s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
Positron emission tomography in
neurology
and cardiology : a review of guidelines and recommendations
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
... to
neurology
, from musculo-skeletal imaging to cardiology. PET has been used with success for the evaluation...
”
Read Now
2
Bobath therapy for patients with
neurological
conditions : a review of clinical effectiveness, cost-effectiveness, and guidelines
by
Gray, Casey
,
Ford, Caitlyn
Published 2018
CADTH
“
... of Bobath therapy for treatment of patients with
neurological
conditions as well as to summarize evidence...
”
Read Now
3
Bobath therapy for patients with
neurological
conditions : a review of clinical effectiveness, cost-effectiveness, and guidelines
by
Gray, Casey
,
Ford, Caitlyn
Published 2018
CADTH
“
... of Bobath therapy for treatment of patients with
neurological
conditions as well as to summarize evidence...
”
Read Now
4
Off-label use of intravenous immunoglobulin for
neurological
conditions : a review of clinical effectiveness
by
Sutton, Desirée
,
Visintini, Sarah
Published 2018
CADTH
“
...Off-label use of IVIG for
neurology
...
”
Read Now
5
Off-label use of intravenous immunoglobulin for
neurological
conditions : a review of clinical effectiveness
by
Sutton, Desirée
,
Visintini, Sarah
Published 2018
CADTH
“
...Off-label use of IVIG for
neurology
...
”
Read Now
6
Off-label use of intravenous immunoglobulin for non-
neurological
paraneoplastic disorders : a review of clinical effectiveness
by
Khangura, Sara
,
Visintini, Sarah
Published 2018
CADTH
“
...Off-label Use of IVIG for non-
neurological
paraneoplastic disorders...
”
Read Now
7
Off-label use of intravenous immunoglobulin for non-
neurological
paraneoplastic disorders : a review of clinical effectiveness
by
Khangura, Sara
,
Visintini, Sarah
Published 2018
CADTH
“
...Off-label Use of IVIG for non-
neurological
paraneoplastic disorders...
”
Read Now
8
Community water fluoridation exposure : a review of neurological and cognitive effects
Published 2019
Canadian Agency for Drugs and Technologies in Health
Read Now
9
Community water fluoridation exposure : a review of neurological and cognitive effects
Published 2019
Canadian Agency for Drugs and Technologies in Health
Read Now
10
Community water fluoridation exposure : a review of neurological and cognitive effects - a 2020 update
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
... that are relevant to the Canadian context on the
neurological
or cognitive development in children and adolescents...
”
Read Now
11
Pharmacoeconomic review report: Glycopyrrolate (Cuvposa) : (Medexus pharmaceuticals, inc.) : indication: chronic severe drooling, neurologic (pediatric)
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
... severe drooling in patients three to 18 years of age with
neurologic
conditions (e.g., cerebral palsy [CP...
”
Read Now
12
Clinical review report: Glycopyrrolate oral solution (Cuvposa) : (Medexus Pharmaceuticals, Inc.) : indication: chronic severe drooling, neurologic (pediatric)
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
... in patients three to 18 years of age with
neurologic
conditions associated with problem drooling...
”
Read Now
13
CADTH Canadian Drug Expert Committee recommendation: Glyopyrrolate oral solution (Cuvposa -- Medexus Pharmaceuticals, Inc.) : indication: chronic severe drooling, neurologic (pedia...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
... to 18 years old with
neurologic
conditions associated with problem drooling (e.g., cerebral palsy...
”
Read Now
14
Brain electrical activity mapping for diagnosing psychiatric disorders : a review of the clinical evidence
Published 2014
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Diagnostic Techniques,
Neurological
...
”
Read Now
15
Brain electrical activity mapping for diagnosing psychiatric disorders : a review of the clinical evidence
Published 2014
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Diagnostic Techniques,
Neurological
...
”
Read Now
16
Foot drop stimulators for foot drop : a review of clinical, cost-effectiveness, and guidelines
by
Ho, Chuong
,
Adcock, Lorna
Published 2018
CADTH
“
... of walking in patients with foot drop caused by various
neurological
conditions, but the effectiveness of FES...
”
Read Now
17
Foot drop stimulators for foot drop : a review of clinical, cost-effectiveness, and guidelines
by
Ho, Chuong
,
Adcock, Lorna
Published 2018
CADTH
“
... of walking in patients with foot drop caused by various
neurological
conditions, but the effectiveness of FES...
”
Read Now
18
Technologies assisting in remote consultations for the diagnosis of stroke : a review of the clinical evidence
Published 2013
Canadian Agency for Drugs and Technologies in Health
“
... hours of symptom onset, and it requires specific
neurological
expertise in order to guide the decision...
”
Read Now
19
Computed tomography angiography versus computed tomography for the diagnosis and management of hyperacute stroke : a review of comparative clinical evidence and guidelines
Published 2013
Canadian Agency for Drugs and Technologies in Health
“
... associated with 0.9% and 0.5% risk of transient and permanent
neurologic
deficits, respectively. Computed...
”
Read Now
20
Computed tomography angiography versus computed tomography for the diagnosis and management of hyperacute stroke : a review of comparative clinical evidence and guidelines
Published 2013
Canadian Agency for Drugs and Technologies in Health
“
... associated with 0.9% and 0.5% risk of transient and permanent
neurologic
deficits, respectively. Computed...
”
1
2
Back
Narrow Search
Remove Filters
Clear Filter
Author: Canadian Agency for Drugs and Technologies in Health
Clear Filter
Collection: National Center for Biotechnology Information
Year of Publication
From:
To:
Classification
610 - Medicine & health
30
330 - Economics
5
363 - Other social problems & services
3
612 - Human physiology
2
410 - Linguistics
1
Language
English
37
Collection
National Center for Biotechnology Information
Author
Canadian Agency for Drugs and Technologies in Health
Visintini, Sarah
4
Canadian Agency for Drugs and Technologies in Health Rapid Response Service
3
Adcock, Lorna
2
De Angelis, Gino
2
Ford, Caitlyn
2
more ...
Frey, Nina
2
Gray, Casey
2
Ho, Chuong
2
Khangura, Sara
2
Poitras, Veronica
2
Sutton, Desirée
2
CADTH Canadian Drug Expert Committee
1
see all ...
less ...
Recently Uploaded
Last Month
2
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=author_facet%3A%22Canadian+Agency+for+Drugs+and+Technologies+in+Health%22&filter%5B%5D=product_txtF_mv%3A%22National+Center+for+Biotechnology+Information%22&lookfor=%22neurology%22&type=AllFields
Send by Email
×
Loading...